X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

TRANSPLANTATION

期刊標題檢索 TRANSPLANTATION 最新評論: Review speed: 2.0 | Submission hit rate: 75.0 Experience sharing: 1 (2024-05-17)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[TRANSPLANTATION]您好,您是該頁面的第 35464 位訪客。

期刊簡介
期刊名稱TRANSPLANTATION TRANSPLANTATION
LetPub Score
7.8
50 ratings
Rate

Reputation
8.7

Influence
6.7

Speed
9.7

期刊簡稱TRANSPLANTATION
ISSN0041-1337
E-ISSN1534-6080
h-index191
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.501.3711.185
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Transplantation
Q16 / 54

自引率 (2023-2024)9.40%自引率趨勢
掲載範囲
The official journal of The Transplantation Society, and the International Liver Transplantation Society, Transplantation is published monthly and is the most cited and influential journal in the field, with more than 25,000 citations per year.

Transplantation has been the trusted source for extensive and timely coverage of the most important advances in transplantation for over 50 years. The Editors and Editorial Board are an international group of research and clinical leaders that includes many pioneers of the field, representing a diverse range of areas of expertise. This capable editorial team provides thoughtful and thorough peer review, and delivers rapid, careful and insightful editorial evaluation of all manuscripts submitted to the journal.

Transplantation is committed to rapid review and publication. The journal remains competitive with a time to first decision of fewer than 21 days. Transplantation was the first in the field to offer CME credit to its peer reviewers for reviews completed.

The journal publishes original research articles in original clinical science and original basic science. Short reports bring attention to research at the forefront of the field. Other areas covered include cell therapy and islet transplantation, immunobiology and genomics, and xenotransplantation. ​
官方網站http://journals.lww.com/transplantjournal/pages/default.aspx
在線稿件提交https://www.editorialmanager.com/TPA
開放訪問No
出版商Lippincott Williams and Wilkins Ltd.
主題領域医学
出版國/地區UNITED STATES
發行頻率月2回刊行
創刊年1963
每年文章數268每年文章數趨勢
黃金OA百分比13.41%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ144/181
SURGERYSCIEQ114/290
TRANSPLANTATIONSCIEQ13/31
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0041-1337%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1 Month(s)
競爭力 *來自作者的數據: About 80%
參考鏈接
相關期刊 【TRANSPLANTATION】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    NATURE IMMUNOLOGYH-index: 344

    CiteScore: 40.00
    Annual Review of ImmunologyH-index: 279

    CiteScore: 57.20
    ImmunityH-index: 355

    CiteScore: 49.40
    Cellular & Molecular ImmunologyH-index: 64

    CiteScore: 31.20
    TRENDS IN IMMUNOLOGYH-index: 209

    CiteScore: 25.10
    JOURNAL OF EXPERIMENTAL MEDICINEH-index: 411

    CiteScore: 26.60
    AUTOIMMUNITY REVIEWSH-index: 103

    CiteScore: 24.70
    BRAIN BEHAVIOR AND IMMUNITYH-index: 127

    CiteScore: 29.60
    JOURNAL OF AUTOIMMUNITYH-index: 101

    CiteScore: 27.90
    學科內最受檢索的期刊 頁面查看次數
    International Immunopharmacology316309
    JOURNAL OF IMMUNOLOGY156694
    Immunity107936
    Cellular & Molecular Immunology107434
    Vaccine104773
    JOURNAL OF EXPERIMENTAL MEDICINE99453
    MICROBIAL PATHOGENESIS94242
    MOLECULAR IMMUNOLOGY91044
    INFLAMMATION89742
    BRAIN BEHAVIOR AND IMMUNITY84729
  •  

    TRANSPLANTATION TRANSPLANTATION
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [TRANSPLANTATION] 的評論撰寫評論
作者: 伏魔凯歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-17 21:15:04 評論於
Review speed: 2.0 | Submission hit rate: 75.0
Experience sharing: 1
(0) 讚! | 伏魔凯歌

作者: 百花莹莹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-05 17:31:57 評論於
Review speed: 1.0 | Submission acceptance rate: 25.0 Emphasis on research topics: Organ transplant experience sharing: Approximately one month per round of review. One major revision was made
(0) 讚! | 百花莹莹

作者: 暗月寺丹红


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-09 21:28:23 評論於
How long does it take to publish?
(0) 讚! | 暗月寺丹红

作者: 百花莹莹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-12 12:45:18 評論於
Can we accept it directly after the renovation is completed?
(0) 讚! | 百花莹莹

作者: 百花莹莹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-12 09:03:59 評論於
My decision on 11-21 is still in process and I haven't received any confirmation yet
(0) 讚! | 百花莹莹

作者: 宗室芳蔼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-08 15:59:47 評論於
Review speed: 2.0 | Submission hit rate: 50.0 Main research direction: organ transplantation; Transplantation experience sharing: Submitted on June 28, 2022, reviewed by two experts during the process, major revisions, requested extension of 1 month for additional experiments, accepted on December 7, 2022. Editor is very good, replies to emails very promptly (usually on the same day when working), borrowing from the advisor's words: reputable old journal
(0) 讚! | 宗室芳蔼

作者: 宗室芳蔼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-08 09:39:31 評論於
It's very good that the magazine is quick in reviewing and approving external opinions
(0) 讚! | 宗室芳蔼

作者: 珉林歌飞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-07 11:14:49 評論於
Review Speed: 1.0
Focus on Research Area: Organ Transplantation Experience Sharing
Submitted on November 1, 2022, Decision in process, it's been almost 5 working days, anxiously waiting
(0) 讚! | 珉林歌飞

作者: 宗室芳蔼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-07 10:33:21 評論於
Review Speed: 6.0 | Submission Hit Rate: 50.0
Emphasized Research Direction: Transplant Experience Sharing
Submitted on 28th June, 2022, reviewed by two experts during the process. Major revisions were required, additional experiments were requested and an extension of one month was granted. Accepted on 7th December, 2022. The editor was very good, replied to emails very promptly (usually on the same day). In the words of my supervisor: a prestigious journal, reliable
(0) 讚! | 宗室芳蔼

作者: 百花莹莹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-24 12:43:51 評論於
How many days for review? I have been under review for over a month
(0) 讚! | 百花莹莹

作者: Martina Jeremy


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-25 08:52:35 評論於
I refused
(0) 讚! | Martina Jeremy

作者: Martina Jeremy


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-21 15:02:55 評論於
Decision in Process
(0) 讚! | Martina Jeremy

作者: Walter Marcellus


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-19 23:02:19 評論於
Decision in process. How will the results be one week later?
(0) 讚! | Walter Marcellus

作者: Martina Jeremy


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-16 19:31:13 評論於
Heavy research focus: Transplantation; sharing liver transplantation experience: submitted on 6-21, not sure how it turned out
(0) 讚! | Martina Jeremy

作者: 宗室芳蔼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-04 18:06:09 評論於
Main Research Focus: Sharing experiences in transplantation. Please advise: Submitted on 6/28, status shows "Submissions Being Processed." Received confirmation email with manuscript number on 6/29. Status has been showing "Similarity Check/iThenticate Results (29%)" since then. Should I revise and resubmit for plagiarism reduction? Or should I wait for the editor's response? Thank you
(0) 讚! | 宗室芳蔼

作者: 雾都景同


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-04 13:25:41 評論於
It was accepted within half a day, the efficiency speed of Americans is quite different from that of European grandfathers, really
(0) 讚! | 雾都景同

作者: 岭南佩杉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-11 23:53:25 評論於
Do we need to select "yes" for open access? Do we need to upload a form if we choose "yes"? I have never encountered this in other journals
(0) 讚! | 岭南佩杉

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 18:32:56 評論於
Medical Subject Headings (MeSH) is a metadata system published by the United States National Library of Medicine, widely used for medical information retrieval. It is used in the field of life sciences for indexing journal articles and books. The main purpose of MeSH is to classify the vast amount of literature in PubMed/MEDLINE
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 11:46:21 評論於
In the field of medicine, most journals and clinical papers particularly recommend the use of MeSH. Using MeSH terms is to help with literature searches and increase the weight of publications
(0) 讚! | 维尔娜菲茨杰拉德

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 19:05:10 評論於
Why screen keywords from MeSH?
(0) 讚! | 平原文波

作者: 魂魄彦露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 20:48:43 評論於
What is MeSH?
(0) 讚! | 魂魄彦露

作者: 岭南佩杉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-02 08:47:17 評論於
Hello, thank you for your reply. I see that you are also doing basic research on liver transplantation. Can I further consult with you? ? I have sent you a private message
(0) 讚! | 岭南佩杉

作者: 排云冠宇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-28 20:51:41 評論於
Do not subjectively guess whether the reviewers and editors like or dislike your article. Respond to all review comments item by item with a learning attitude, trying your best to supplement experiments according to the review comments. Good articles are never written, they are revised. Let the reviewers and editors see your attitude and sincerity in revising, and the article can naturally be published smoothly. After revision, it will be sent back to the original editors and reviewers for a second review. Hope this is helpful to you
(0) 讚! | 排云冠宇

作者: 岭南佩杉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-27 19:20:58 評論於
Hello, I am currently in major revision status. However, one reviewer suggested minor revisions while another suggested major revisions, but both stated that the article is acceptable. I am confused as to why the editor's comments seem to indicate a dislike for the article. Also, I am unsure if the major revisions are to be addressed to the original reviewer or a new reviewer. I would appreciate your response. Thank you
(0) 讚! | 岭南佩杉

作者: 排云冠宇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-13 08:07:19 評論於
Review speed: 1.0 | Submission hit rate: 50.0 Emphasized research direction: Liver transplantation experience sharing: Liver transplantation basic research, article submitted on April 6, 2021; major revision on May 5, 2021, revised second review on June 30, 2021; minor revision on July 17, 2021, revised on July 28, 2021 Accepted on August 17, 2021! Experience: 2 professional editors + 2 reviewers, rigorous review process, professional questioning! Do not have a lucky mentality, be sure to improve the manuscript, ensure quality before considering submission! This will greatly shorten the submission cycle and increase the probability of acceptance
(0) 讚! | 排云冠宇

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [TRANSPLANTATION] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*